Learn More
Medchemexpress LLC N2-(1H-Indol-5-yl)-6-(pyridin-4-yl)pyrazine-2,3-diamine acetate | 98.4% | 362.39 | 25 MG

Supplier: Medchemexpress LLC 25MGHY118304B
AKN-028 acetate is a novel tyrosine kinase (TK) inhibitor and a potent, orally active FMS-like receptor tyrosine kinase 3 (FLT3) inhibitor with an IC50 value of 6 nM. It inhibits FLT3 autophosphorylation, induces a dose-dependent cytotoxic response (mean IC50=1 μM), and induces apoptosis by activation of caspase 3. AKN-028 acetate can be used in research of acute myeloid leukemia (AML).
- Potent, orally active FMS-like receptor tyrosine kinase 3 (FLT3) inhibitor with an IC50 of 6 nM.
- Inhibits FLT3 autophosphorylation.
- Induces dose-dependent cytotoxic response (mean IC50=1 μM).
- Induces apoptosis by activation of caspase 3.
- Inhibits growth of primary AML and MV4-11 cells in mice.
- Useful in research of acute myeloid leukemia (AML).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.